Curious about how digital pathology is transforming HER2 analysis in breast cancer? Watch this webinar on demand to explore the nuances of HER2 IHC expression, understand the role of in situ-hybridization, and uncover the benefits of AI-powered scoring and assessment techniques.

Dr. Baldwin provides a comprehensive review of the levels of HER2 IHC expression and examines the advantages of incorporating HER2 in situ-hybridization into the pathology laboratory workflow.

Dr. Bennett reviews the benefits and utility of AI assistive tools in HER2 scoring and assessment in breast cancer. She will then demonstrate a HER2 scoring workflow incorporating digital and AI tools.

navify® Digital Pathology software is intended for specific clinical applications and is for research and educational use for other applications. Please review the product labeling for compliance before utilization.


HER2(4B5) Image Analysis Algorithm by navify Digital Pathology and uPath HER2 Dual ISH Image Analysis Algorithm, Breast, are for research use only. Not for use in diagnostic procedures.

 

Interested in learning more? Fill out the form below to be contacted by a Roche representative.

 

Roche Diagnostics

9115 Hague Road

Indianapolis, IN 46256

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin. © 2025 Roche Diagnostics